Categorías
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
beta-Nicotinamide adenine dinucleotide phosphate disodium salt
(42474095 | 24292-60-2)
CAS: | 24292-60-2 |
---|---|
Fórmula molecular: | C21H26N7Na2O17P3 |
Peso molecular: | 787.37 |
Disponibilidad: | En stock |
---|---|
Descargas: | | |
42474095-1g | 1g | £62.10 | |
Pedido bulk |
42474095-1g | 1g | €87.00 | |
Pedido bulk |
42474095-1g | 1g | $93.20 | |
Pedido bulk |
Ficha de datos de seguridad
Certificado de análisis
Detalle del producto
Product Code | 42474095 | ||||
Product Name | beta-Nicotinamide adenine dinucleotide phosphate disodium salt | ||||
Categories | Biochemicals | ||||
CAS | 24292-60-2 | ||||
Molecular Formula | C21H26N7Na2O17P3 | ||||
Molecular Weight | 787.37 | ||||
Storage Details | -15 to -20 °C | ||||
Harmonised Tariff Code | 29349990 |
Especificaciones del producto
Solubility | 200 mg/ml in water | ||||
Appearance | White to yellow powder | ||||
A250/A260 | 0.83 ± 0.03 | ||||
A280/A260 | 0.21 ± 0.02 | ||||
A340/A260 | 0.43 ± 0.02 | ||||
Water Content ( Karl Fisher) | ≤8% | ||||
NADP (HPLC Purity) | ≥93% | ||||
NADP content | ≥90% |
Información de seguridad
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|